Pluri Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pluri Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-12-31 was 0.00 shares.
- Pluri Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-09-30 was 6.00K shares, a 76.00% decline year-over-year.
- Pluri Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Pluri Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-03-31 was 3.00K shares, a 40.00% decline year-over-year.
- Pluri Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 28.00K shares, a 100.00% increase from fiscal 2015.
- Pluri Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 14.00K shares, a 6.67% decline from fiscal 2014.
- Pluri Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2014 was 15.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2016-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | 9.00K shares derived: sum of 4 quarters · filed 2017-02-08 |
| 2016-09-30 | 6.00K shares 10-Q · filed 2016-11-07 | 9.00K shares derived: sum of 4 quarters · filed 2016-11-07 |
| 2016-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | 28.00K shares 10-K · filed 2016-09-07 |
| 2016-03-31 | 3.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | 34.00K shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | 36.00K shares derived: sum of 4 quarters · filed 2016-02-08 |
| 2015-09-30 | 25.00K shares 10-Q · filed 2015-11-05 | 36.00K shares derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | 6.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | 14.00K shares 10-K · filed 2015-09-09 |
| 2015-03-31 | 5.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | 8.00K shares derived: sum of 4 quarters · filed 2015-05-06 |
| 2014-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | |
| 2014-09-30 | 3.00K shares 10-Q · filed 2014-11-06 | |
| 2014-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | 15.00K shares 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |